Toggle navigation
Home
Search
Services
Blog
Contact
About
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J.
Cbr Laboratories, Inc., Boston, MA, United States
Search 3 grants from Robert Mandle
Search grants from Cbr Laboratories, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
ROBAS: A Multimodal Sensor System for Remote Assessment of Oral Health Behaviors
CORAL: Data Coordinating Center
eNOS-actin Interaction and Oxygen in Lung Endothelium
Genetics and Receptor Mechanisms in Hypertension
A New Instrument for Biomedical Research
Recently added grants:
Defining the Inflammation and Immunity Transcriptome in Severe Malarial Anemia for Immunotherapeutic Discovery
Heme and hemoglobin utilization by Mycobacterium tuberculosis
Ocular Sequelae and Intervention in a Rat Model of Blast Overpressure Polytrauma
Deconvolution of pro- and anti-viral responses to Dengue virus and Zika Virus infections
Regulation of the IgG Fc domain repertoire
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44HL052290-03
Application #
2229597
Study Section
Special Emphasis Panel (ZRG7-SSS-Z (18))
Project Start
1993-08-10
Project End
1998-04-30
Budget Start
1996-05-01
Budget End
1998-04-30
Support Year
3
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Cbr Laboratories, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02115
Related projects
NIH 1996
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
NIH 1995
R44 HL
Preclinical Study of Recombinant Elastase Inhibitor
Mandle, Robert J. / Cbr Laboratories, Inc.
Comments
Be the first to comment on Robert Mandle's grant